A Novel Therapeutic Target for Mitochondrial Dysfunction
Mitochondrial dysfunction contributes significantly to a wide range of chronic diseases. This impairment in mitochondrial function can lead to cellular failure, ultimately resulting in diverse pathologies. EPT Fumarate, a novel therapeutic agent, has emerged as a promising approach for addressing this debilitating issue. EPT Fumarate operates by e